2023-09-13 |
2023-09-11 |
B
Purchase
|
Celebi John
President and CEO
Executive Director
|
500
+0.5%
0.85
425
USD
|
500
+0.5%
|
0.85
|
425
USD
|
|
2023-06-02 |
2023-06-01 |
S
Sale
|
Apeiron Investment Group Ltd.
Major owner
|
955,738
-100.0%
1.58
1,510,066
USD
|
955,738
-100.0%
|
1.58
|
1,510,066
USD
|
|
2023-06-02 |
2023-06-01 |
S
Sale
|
Apeiron Investment Group Ltd.
Major owner
|
2,485,923
-100.0%
1.58
3,927,758
USD
|
2,485,923
-100.0%
|
1.58
|
3,927,758
USD
|
|
2023-02-27 |
2023-02-23 |
B
Purchase
|
Apeiron Investment Group Ltd.
Major owner
|
1,100
+0.0%
1.60
1,763
USD
|
1,100
+0.0%
|
1.60
|
1,763
USD
|
|
2023-02-27 |
2023-02-23 |
B
Purchase
|
Apeiron Investment Group Ltd.
Major owner
|
1,100
+0.0%
1.62
1,777
USD
|
1,100
+0.0%
|
1.62
|
1,777
USD
|
|
2022-03-02 |
2022-03-02 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
1,203
+0.0%
3.20
3,850
USD
|
1,203
+0.0%
|
3.20
|
3,850
USD
|
|
2022-03-02 |
2022-03-02 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
1,203
+0.0%
3.20
3,850
USD
|
1,203
+0.0%
|
3.20
|
3,850
USD
|
|
2022-03-01 |
2022-03-01 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
2,458
+0.0%
3.60
8,849
USD
|
2,458
+0.0%
|
3.60
|
8,849
USD
|
|
2022-03-01 |
2022-03-01 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
2,458
+0.0%
3.60
8,849
USD
|
2,458
+0.0%
|
3.60
|
8,849
USD
|
|
2022-03-01 |
2022-02-28 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
42
+0.0%
3.60
151
USD
|
42
+0.0%
|
3.60
|
151
USD
|
|
2022-03-01 |
2022-02-28 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
42
+0.0%
3.60
151
USD
|
42
+0.0%
|
3.60
|
151
USD
|
|
2022-02-28 |
2022-02-25 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
2,500
+0.0%
3.65
9,125
USD
|
2,500
+0.0%
|
3.65
|
9,125
USD
|
|
2022-02-28 |
2022-02-25 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
2,500
+0.0%
3.65
9,125
USD
|
2,500
+0.0%
|
3.65
|
9,125
USD
|
|
2022-02-24 |
2022-02-24 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
15,000
+0.3%
3.63
54,450
USD
|
15,000
+0.3%
|
3.63
|
54,450
USD
|
|
2022-02-24 |
2022-02-24 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
15,000
+0.3%
3.63
54,450
USD
|
15,000
+0.3%
|
3.63
|
54,450
USD
|
|
2022-02-24 |
2022-02-23 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
2,500
+0.0%
3.80
9,500
USD
|
2,500
+0.0%
|
3.80
|
9,500
USD
|
|
2022-02-24 |
2022-02-23 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
2,500
+0.0%
3.80
9,500
USD
|
2,500
+0.0%
|
3.80
|
9,500
USD
|
|
2022-02-22 |
2022-02-18 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
15,000
+0.3%
3.97
59,550
USD
|
15,000
+0.3%
|
3.97
|
59,550
USD
|
|
2022-02-22 |
2022-02-18 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
15,000
+0.3%
3.97
59,550
USD
|
15,000
+0.3%
|
3.97
|
59,550
USD
|
|
2022-02-22 |
2022-02-17 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
4,949
+0.1%
4.17
20,637
USD
|
4,949
+0.1%
|
4.17
|
20,637
USD
|
|
2022-02-22 |
2022-02-17 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
4,949
+0.1%
4.17
20,637
USD
|
4,949
+0.1%
|
4.17
|
20,637
USD
|
|
2022-02-16 |
2022-02-16 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
2,551
+0.0%
4.25
10,842
USD
|
2,551
+0.0%
|
4.25
|
10,842
USD
|
|
2022-02-16 |
2022-02-16 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
2,551
+0.0%
4.25
10,842
USD
|
2,551
+0.0%
|
4.25
|
10,842
USD
|
|
2022-02-16 |
2022-02-14 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
10,000
+0.2%
4.18
41,800
USD
|
10,000
+0.2%
|
4.18
|
41,800
USD
|
|
2022-02-16 |
2022-02-14 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
10,000
+0.2%
4.18
41,800
USD
|
10,000
+0.2%
|
4.18
|
41,800
USD
|
|
2022-02-14 |
2022-02-11 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
12,500
+0.2%
4.40
55,000
USD
|
12,500
+0.2%
|
4.40
|
55,000
USD
|
|
2022-02-14 |
2022-02-11 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
12,500
+0.2%
4.40
55,000
USD
|
12,500
+0.2%
|
4.40
|
55,000
USD
|
|
2022-02-14 |
2022-02-10 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
5,000
+0.1%
4.58
22,900
USD
|
5,000
+0.1%
|
4.58
|
22,900
USD
|
|
2022-02-14 |
2022-02-10 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
5,000
+0.1%
4.58
22,900
USD
|
5,000
+0.1%
|
4.58
|
22,900
USD
|
|
2022-02-08 |
2022-02-08 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
10,000
+0.2%
4.33
43,300
USD
|
10,000
+0.2%
|
4.33
|
43,300
USD
|
|
2022-02-08 |
2022-02-08 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
10,000
+0.2%
4.33
43,300
USD
|
10,000
+0.2%
|
4.33
|
43,300
USD
|
|
2022-02-08 |
2022-02-04 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
2,500
+0.0%
4.45
11,125
USD
|
2,500
+0.0%
|
4.45
|
11,125
USD
|
|
2022-02-08 |
2022-02-04 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
2,500
+0.0%
4.45
11,125
USD
|
2,500
+0.0%
|
4.45
|
11,125
USD
|
|
2022-02-08 |
2022-02-03 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
17,500
+0.3%
4.65
81,375
USD
|
17,500
+0.3%
|
4.65
|
81,375
USD
|
|
2022-02-08 |
2022-02-03 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
17,500
+0.3%
4.65
81,375
USD
|
17,500
+0.3%
|
4.65
|
81,375
USD
|
|
2022-01-31 |
2022-01-28 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
8,900
+0.2%
4.22
37,558
USD
|
8,900
+0.2%
|
4.22
|
37,558
USD
|
|
2022-01-31 |
2022-01-28 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
8,900
+0.2%
4.22
37,558
USD
|
8,900
+0.2%
|
4.22
|
37,558
USD
|
|
2022-01-31 |
2022-01-27 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
6,100
+0.1%
4.31
26,291
USD
|
6,100
+0.1%
|
4.31
|
26,291
USD
|
|
2022-01-31 |
2022-01-27 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
6,100
+0.1%
4.31
26,291
USD
|
6,100
+0.1%
|
4.31
|
26,291
USD
|
|
2022-01-27 |
2022-01-26 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
29,900
+0.6%
4.62
138,138
USD
|
29,900
+0.6%
|
4.62
|
138,138
USD
|
|
2022-01-27 |
2022-01-26 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
29,900
+0.6%
4.62
138,138
USD
|
29,900
+0.6%
|
4.62
|
138,138
USD
|
|
2022-01-27 |
2022-01-25 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
20,100
+0.4%
4.86
97,686
USD
|
20,100
+0.4%
|
4.86
|
97,686
USD
|
|
2022-01-27 |
2022-01-25 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
20,100
+0.4%
4.86
97,686
USD
|
20,100
+0.4%
|
4.86
|
97,686
USD
|
|
2022-01-25 |
2022-01-24 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
22,707
+0.5%
4.69
106,496
USD
|
22,707
+0.5%
|
4.69
|
106,496
USD
|
|
2022-01-25 |
2022-01-24 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
22,707
+0.5%
4.69
106,496
USD
|
22,707
+0.5%
|
4.69
|
106,496
USD
|
|
2022-01-25 |
2022-01-21 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
24,703
+0.5%
4.94
122,033
USD
|
24,703
+0.5%
|
4.94
|
122,033
USD
|
|
2022-01-25 |
2022-01-21 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
24,703
+0.5%
4.94
122,033
USD
|
24,703
+0.5%
|
4.94
|
122,033
USD
|
|
2022-01-21 |
2022-01-20 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
20,000
+0.4%
5.17
103,400
USD
|
20,000
+0.4%
|
5.17
|
103,400
USD
|
|
2022-01-21 |
2022-01-20 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
20,000
+0.4%
5.17
103,400
USD
|
20,000
+0.4%
|
5.17
|
103,400
USD
|
|
2022-01-21 |
2022-01-19 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
10,244
+0.2%
4.97
50,913
USD
|
10,244
+0.2%
|
4.97
|
50,913
USD
|
|
2022-01-21 |
2022-01-19 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
10,244
+0.2%
4.97
50,913
USD
|
10,244
+0.2%
|
4.97
|
50,913
USD
|
|
2022-01-20 |
2022-01-18 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
10,000
+0.2%
5.08
50,800
USD
|
10,000
+0.2%
|
5.08
|
50,800
USD
|
|
2022-01-20 |
2022-01-18 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
10,000
+0.2%
5.08
50,800
USD
|
10,000
+0.2%
|
5.08
|
50,800
USD
|
|
2022-01-18 |
2022-01-14 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
6,219
+0.1%
4.99
31,033
USD
|
6,219
+0.1%
|
4.99
|
31,033
USD
|
|
2022-01-18 |
2022-01-14 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
6,219
+0.1%
4.99
31,033
USD
|
6,219
+0.1%
|
4.99
|
31,033
USD
|
|
2022-01-18 |
2022-01-13 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
19,953
+0.4%
5.13
102,359
USD
|
19,953
+0.4%
|
5.13
|
102,359
USD
|
|
2022-01-18 |
2022-01-13 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
19,953
+0.4%
5.13
102,359
USD
|
19,953
+0.4%
|
5.13
|
102,359
USD
|
|
2022-01-13 |
2022-01-12 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
9,202
+0.2%
5.22
48,034
USD
|
9,202
+0.2%
|
5.22
|
48,034
USD
|
|
2022-01-13 |
2022-01-12 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
9,202
+0.2%
5.22
48,034
USD
|
9,202
+0.2%
|
5.22
|
48,034
USD
|
|
2022-01-13 |
2022-01-11 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
10,845
+0.2%
5.18
56,177
USD
|
10,845
+0.2%
|
5.18
|
56,177
USD
|
|
2022-01-13 |
2022-01-11 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
10,845
+0.2%
5.18
56,177
USD
|
10,845
+0.2%
|
5.18
|
56,177
USD
|
|
2022-01-11 |
2022-01-10 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
10,000
+0.2%
5.28
52,800
USD
|
10,000
+0.2%
|
5.28
|
52,800
USD
|
|
2022-01-11 |
2022-01-10 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
10,000
+0.2%
5.28
52,800
USD
|
10,000
+0.2%
|
5.28
|
52,800
USD
|
|
2022-01-03 |
2021-12-30 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
1,127
+0.0%
4.85
5,466
USD
|
1,127
+0.0%
|
4.85
|
5,466
USD
|
|
2022-01-03 |
2021-12-30 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
1,127
+0.0%
4.85
5,466
USD
|
1,127
+0.0%
|
4.85
|
5,466
USD
|
|
2021-12-23 |
2021-12-23 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
11,000
+0.2%
5.27
57,970
USD
|
11,000
+0.2%
|
5.27
|
57,970
USD
|
|
2021-12-23 |
2021-12-23 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
11,000
+0.2%
5.27
57,970
USD
|
11,000
+0.2%
|
5.27
|
57,970
USD
|
|
2021-12-21 |
2021-12-17 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
117
+0.0%
5.29
619
USD
|
117
+0.0%
|
5.29
|
619
USD
|
|
2021-12-21 |
2021-12-17 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
117
+0.0%
5.29
619
USD
|
117
+0.0%
|
5.29
|
619
USD
|
|
2021-12-20 |
2021-12-16 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
10,925
+0.2%
5.25
57,356
USD
|
10,925
+0.2%
|
5.25
|
57,356
USD
|
|
2021-12-20 |
2021-12-16 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
10,925
+0.2%
5.25
57,356
USD
|
10,925
+0.2%
|
5.25
|
57,356
USD
|
|
2021-12-13 |
2021-12-10 |
B
Purchase
|
RICKS THOMAS G
Non-Executive Director
|
20,000
+6.2%
5.86
117,200
USD
|
20,000
+6.2%
|
5.86
|
117,200
USD
|
|
2021-12-13 |
2021-12-09 |
B
Purchase
|
RICKS THOMAS G
Non-Executive Director
|
20,000
+6.6%
6.62
132,400
USD
|
20,000
+6.6%
|
6.62
|
132,400
USD
|
|
2021-05-06 |
2021-05-05 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
350
+0.0%
12.00
4,200
USD
|
350
+0.0%
|
12.00
|
4,200
USD
|
|
2021-04-21 |
2021-04-20 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
385
+0.0%
12.77
4,916
USD
|
385
+0.0%
|
12.77
|
4,916
USD
|
|